Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU

Recruiting Observational Study
Septic Shock Hemodynamic Instability Vasoconstriction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
45 (estimated)
Sponsor
Copenhagen University Hospital, Hvidovre · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In septic shock there is growing evidence of a state of hemodynamic "disconnection" with seemingly adequate macrocirculatory values despite actual microcirculation failing to meet cellular demand. Norepinephrine (NE) is recommended as first choice vasoactive agent for the treatment of septic shock. However, the dynamic effects of NE on macro- and microcirculation and perfusion parameters has not b…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Suspected or documented infection * Need for vasopressors to maintain mean arterial blood pressure (MAP) ≥65 mmHg * Serum lactate levels \>2 mmol/L * Norepinephrine infusion of \> 0.2 mcg/kg/min Exclusion Criteria: * Absolute contraindication for esophageal doppler or urinar…
Contacts

Henrik Wolsted, MD

+45 21 49 44 85

Henrik.wolsted.01@regionh.dk

CONTACT

Nicolai Bang Foss, MD, DMsC

nicolai.bang.foss@regionh.dk

CONTACT